Silence Therapeutics Plc ADR (SLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,906 | -15,395 | -58,590 | -38,064 | -28,867 |
| Depreciation Amortization | 316 | 163 | 596 | 402 | 285 |
| Accounts receivable | -14,751 | -945 | -722 | 237 | -3,227 |
| Accounts payable and accrued liabilities | -1,010 | 509 | 1,790 | 4,418 | 915 |
| Other Working Capital | -17,780 | -8,834 | -9,600 | -3,559 | -6,270 |
| Other Operating Activity | 35,819 | 15,202 | 10,301 | -1,179 | 8,733 |
| Operating Cash Flow | $-28,313 | $-9,301 | $-56,225 | $-37,746 | $-28,430 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30 | -33 | -173 | -161 | -113 |
| Purchase Of Investment | 20,133 | N/A | -19,945 | N/A | N/A |
| Purchase Sale Intangibles | -25,873 | -7 | -371 | N/A | N/A |
| Other Investing Activity | -25,837 | 188 | -343 | 11 | 5 |
| Investing Cash Flow | $-5,735 | $156 | $-20,461 | $-151 | $-108 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,113 | 81 | 53,482 | 50,783 | 49 |
| Other Financing Activity | -103 | -58 | -235 | -132 | -122 |
| Financing Cash Flow | $4,011 | $23 | $53,247 | $50,651 | $-73 |
| Exchange Rate Effect | -1,386 | -700 | 282 | 6,656 | 1,025 |
| Beginning Cash Position | 68,635 | 66,591 | 90,958 | 86,612 | 92,326 |
| End Cash Position | 37,212 | 56,769 | 67,802 | 106,022 | 64,740 |
| Net Cash Flow | $-31,423 | $-9,822 | $-23,156 | $19,410 | $-27,586 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,313 | -9,301 | -56,225 | -37,746 | -28,430 |
| Capital Expenditure | -30 | -33 | -173 | -161 | -113 |
| Free Cash Flow | -28,343 | -9,333 | -56,398 | -37,908 | -28,543 |